Lescan Mario, Andic Mateja, Krüger Tobias, Ivosevic Vedran, Schlensak Christian
Department of Thoracic and Cardiovascular Surgery, University Medical Center Tübingen, Tübingen, Germany.
Thorac Cardiovasc Surg. 2019 Aug;67(5):385-392. doi: 10.1055/s-0038-1669935. Epub 2018 Sep 22.
Ascending aorta or hemi-arch repair are common in the acute phase of type A dissection. Postdissection aneurysms can develop with antegrade perfusion of the false lumen in the dissected aortic arch and require reoperation.
From 2012 to 2018, we reoperated nine patients with postdissection aneurysms using a hybrid technique without cardiopulmonary bypass. The patients had a EuroSCORE II of 13% and a logistic EuroSCORE I of 45% and were not candidates for frozen elephant trunk surgery. The median interval since the acute ascending repair was 184 (92; 528) days. All patients were treated by median resternotomy, ascending to carotid bypass on a partially clamped ascending graft, and transfemoral endovascular repair with a Relay NBS (nonbare stent) or conformable Gore C-TAG stent graft.
Technical success was achieved in all cases. Mean follow-up was 405 (220; 672) days. There was no disabling stroke, endoleak, paraplegia, in-hospital, or late mortality. In all patients, the false lumen was completely thrombosed at the aortic arch level with a median aneurysm shrinkage of 13 mm in the distal arch. There was no bird beak or stent graft migration. Distal stent-induced new entry was observed in one case. Reinterventions were not necessary due to diameter stability.
Complete debranching with transfemoral thoracic endovascular aneurysm repair showed encouraging results in patients with relevant comorbidities. The used stent grafts performed well in the mid-term follow-up period with no endoleaks or migration.
升主动脉或半弓修复在A型主动脉夹层急性期较为常见。夹层后动脉瘤可因主动脉弓夹层假腔的顺行灌注而形成,需要再次手术。
2012年至2018年,我们采用非体外循环杂交技术对9例夹层后动脉瘤患者进行了再次手术。患者的欧洲心脏手术风险评估系统(EuroSCORE)II评分为13%,逻辑EuroSCORE I评分为45%,不适合进行象鼻支架植入术。自急性升主动脉修复后的中位间隔时间为184(92;528)天。所有患者均接受正中胸骨切开术,在部分阻断的升主动脉移植物上进行升主动脉至颈动脉旁路移植,并采用Relay NBS(非裸支架)或顺应性戈尔C-TAG支架移植物经股动脉进行血管腔内修复。
所有病例均取得技术成功。平均随访时间为405(220;672)天。无致残性卒中、内漏、截瘫、住院期间或晚期死亡。所有患者的主动脉弓水平假腔均完全血栓形成,远端弓部动脉瘤中位缩小13 mm。无鸟嘴样改变或支架移植物移位。1例观察到远端支架引起的新破口。由于直径稳定,无需再次干预。
经股动脉胸主动脉腔内动脉瘤修复术完全去分支在合并相关疾病的患者中显示出令人鼓舞的结果。所用的支架移植物在中期随访中表现良好,无内漏或移位。